These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 35613279)
1. Aberrant methylmalonylation underlies methylmalonic acidemia and is attenuated by an engineered sirtuin. Head PE; Myung S; Chen Y; Schneller JL; Wang C; Duncan N; Hoffman P; Chang D; Gebremariam A; Gucek M; Manoli I; Venditti CP Sci Transl Med; 2022 May; 14(646):eabn4772. PubMed ID: 35613279 [TBL] [Abstract][Full Text] [Related]
2. New insights into the pathophysiology of methylmalonic acidemia. Head PE; Meier JL; Venditti CP J Inherit Metab Dis; 2023 May; 46(3):436-449. PubMed ID: 37078237 [TBL] [Abstract][Full Text] [Related]
3. Pre-clinical efficacy and dosing of an AAV8 vector expressing human methylmalonyl-CoA mutase in a murine model of methylmalonic acidemia (MMA). Chandler RJ; Venditti CP Mol Genet Metab; 2012 Nov; 107(3):617-9. PubMed ID: 23046887 [TBL] [Abstract][Full Text] [Related]
4. Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes. Collado MS; Armstrong AJ; Olson M; Hoang SA; Day N; Summar M; Chapman KA; Reardon J; Figler RA; Wamhoff BR Mol Genet Metab; 2020 Jul; 130(3):183-196. PubMed ID: 32451238 [TBL] [Abstract][Full Text] [Related]
5. Growth advantage of corrected hepatocytes in a juvenile model of methylmalonic acidemia following liver directed adeno-associated viral mediated nuclease-free genome editing. Venturoni LE; Chandler RJ; Liao J; Hoffmann V; Ramesh N; Gordo S; Chau N; Venditti CP Mol Genet Metab; 2022; 137(1-2):1-8. PubMed ID: 35868241 [TBL] [Abstract][Full Text] [Related]
6. Neutralizing Antibodies Against Adeno-Associated Viral Capsids in Patients with mut Methylmalonic Acidemia. Harrington EA; Sloan JL; Manoli I; Chandler RJ; Schneider M; McGuire PJ; Calcedo R; Wilson JM; Venditti CP Hum Gene Ther; 2016 May; 27(5):345-53. PubMed ID: 26790480 [TBL] [Abstract][Full Text] [Related]
7. Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria. Wongkittichote P; Cunningham G; Summar ML; Pumbo E; Forny P; Baumgartner MR; Chapman KA Mol Genet Metab; 2019 Dec; 128(4):444-451. PubMed ID: 31648943 [TBL] [Abstract][Full Text] [Related]
8. A novel small molecule approach for the treatment of propionic and methylmalonic acidemias. Armstrong AJ; Collado MS; Henke BR; Olson MW; Hoang SA; Hamilton CA; Pourtaheri TD; Chapman KA; Summar MM; Johns BA; Wamhoff BR; Reardon JE; Figler RA Mol Genet Metab; 2021 May; 133(1):71-82. PubMed ID: 33741272 [TBL] [Abstract][Full Text] [Related]
9. Long-term rescue of a lethal murine model of methylmalonic acidemia using adeno-associated viral gene therapy. Chandler RJ; Venditti CP Mol Ther; 2010 Jan; 18(1):11-6. PubMed ID: 19861951 [TBL] [Abstract][Full Text] [Related]
10. Promoterless, Nuclease-Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic Acidemia. Chandler RJ; Venturoni LE; Liao J; Hubbard BT; Schneller JL; Hoffmann V; Gordo S; Zang S; Ko CW; Chau N; Chiang K; Kay MA; Barzel A; Venditti CP Hepatology; 2021 Jun; 73(6):2223-2237. PubMed ID: 32976669 [TBL] [Abstract][Full Text] [Related]
19. Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency. Almási T; Guey LT; Lukacs C; Csetneki K; Vokó Z; Zelei T Orphanet J Rare Dis; 2019 Apr; 14(1):84. PubMed ID: 31023387 [TBL] [Abstract][Full Text] [Related]
20. Correction of methylmalonyl-CoA mutase deficiency in Mut0 fibroblasts and constitution of gene expression in primary human hepatocytes by retroviral-mediated gene transfer. Sawada T; Ledley FD Somat Cell Mol Genet; 1992 Nov; 18(6):507-16. PubMed ID: 1363156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]